History of INJ
Injective Protocol, commonly known by its ticker symbol INJ, was founded in 2017 by Eric Chen and Albert Chon. The project's goal was to create a decentralized, permissionless, and fully scalable infrastructure for decentralized finance (DeFi) applications. The key focus of Injective Protocol has been decentralized exchanges (DEXs) that provide users with the ability to trade crypto assets without relying on intermediaries, bringing the benefits of self-custody and censorship resistance.
The early development of Injective Protocol was marked by a desire to solve some of the most common problems in the cryptocurrency and DeFi ecosystem. Among its primary innovations was the use of Layer-2 blockchain technology, which allowed it to significantly increase transaction speed and reduce costs compared to other platforms. This feature was particularly attractive to users who were frustrated with the congestion and high fees on Ethereum and other Layer-1 platforms.
In 2018, the project gained further attention after becoming part of Binance Labs Incubation Program. This gave Injective both financial backing and access to Binance's extensive resources, including access to its user base and marketing channels. The support from Binance played a pivotal role in the protocol's early growth, positioning it as a competitive player in the DeFi space.
Another milestone for Injective came with the launch of the Injective Chain, a fully decentralized sidechain built on Cosmos SDK utilizing Tendermint as the consensus mechanism. As a Layer-2 DEX protocol, Injective allows for cross-chain asset transfers between Ethereum and other blockchain platforms, something which Injective has touted as an important step for interoperability in the DeFi world.
The governance aspect of Injective Protocol is also significant. INJ, the native token of the ecosystem, acts as both a governance token and a utility token, enabling holders to participate in protocol decisions and helping secure the platform through staking. INJ is also utilized for liquidity mining, transaction fee discounts, and collateral backings.
Since its inception, Injective has steadily grown with integrations across multiple DeFi ecosystems and has continued to collaborate with developers and partners to expand its offering. The platform's modular nature allows for the deployment of various financial instruments, including perpetual swaps, futures, and synthetic assets, positioning it as a robust protocol aimed at driving the next generation of decentralized finance.
